skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Base de dados/Biblioteca: ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Pastore, Alessandro, MD ; Jurinovic, Vindi, Dipl Math ; Kridel, Robert, MD ; Hoster, Eva, PhD ; Staiger, Annette M, MSc ; Szczepanowski, Monika, PhD ; Pott, Christiane, MD ; Kopp, Nadja, MSc ; Murakami, Mark, MD ; Horn, Heike, PhD ; Leich, Ellen, PhD ; Moccia, Alden A, MD ; Mottok, Anja, MD ; Sunkavalli, Ashwini, MSc ; Van Hummelen, Paul, PhD ; Ducar, Matthew, MSc ; Ennishi, Daisuke, PhD ; Shulha, Hennady P, PhD ; Hother, Christoffer, MD ; Connors, Joseph M, Prof ; Sehn, Laurie H, MD ; Dreyling, Martin, Prof ; Neuberg, Donna, ScD ; Möller, Peter, Prof ; Feller, Alfred C, Prof ; Hansmann, Martin L, Prof ; Stein, Harald, Prof ; Rosenwald, Andreas, Prof ; Ott, German, Prof ; Klapper, Wolfram, Prof ; Unterhalt, Michael, PhD ; Hiddemann, Wolfgang, Prof ; Gascoyne, Randy D, Prof ; Weinstock, David M, MD ; Weigert, Oliver, Dr

The lancet oncology, 2015-09, Vol.16 (9), p.1111-1122 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

Palanca-Wessels, Maria Corinna A, Dr ; Czuczman, Myron, Prof ; Salles, Gilles, Prof ; Assouline, Sarit, MD ; Sehn, Laurie H, MD ; Flinn, Ian, MD ; Patel, Manish R, MD ; Sangha, Randeep, MD ; Hagenbeek, Anton, MD ; Advani, Ranjana, MD ; Tilly, Herve, Prof ; Casasnovas, Olivier, MD ; Press, Oliver W, Prof ; Yalamanchili, Sreeni, PharmD ; Kahn, Robert, MD ; Dere, Randall C, BSc ; Lu, Dan, PhD ; Jones, Surai, MS ; Jones, Cheryl, ScD ; Chu, Yu-Waye, MD ; Morschhauser, Franck, Prof

The lancet oncology, 2015-06, Vol.16 (6), p.704-715 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada
Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada

Johnston, Karissa M., PhD ; Marra, Carlo A., PhD ; Connors, Joseph M., MD ; Najafzadeh, Mehdi, MSc ; Sehn, Laurie, MD ; Peacock, Stuart J., DPhil

Value in health, 2010-09, Vol.13 (6), p.703-711 [Periódico revisado por pares]

Malden, USA: Elsevier Inc

Texto completo disponível

Citações Citado por
4
The Increasing Complexity of Aggressive B-cell Lymphoma
The Increasing Complexity of Aggressive B-cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Increasing Complexity of Aggressive B-cell Lymphoma

Sehn, Laurie H., MD, MPH

Hematology/oncology clinics of North America, 2016-12, Vol.30 (6), p.xiii-xiv [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diffuse Large B-Cell Lymphoma

Giné, Eva, MD ; Sehn, Laurie H., MD, MPH

Hematology/oncology clinics of North America, 2016-12, Vol.30 (6), p.1179-1194 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
Ovarian complete hydatidiform mole: case study with molecular analysis and review of the literature
Ovarian complete hydatidiform mole: case study with molecular analysis and review of the literature
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ovarian complete hydatidiform mole: case study with molecular analysis and review of the literature

Sehn, Jennifer K., MD ; Kuroki, Lindsay M., MD ; Hopeman, Margaret M., MD ; Longman, Ryan E., MD ; McNicholas, Colleen P., DO ; Huettner, Phyllis C., MD

Human pathology, 2013-12, Vol.44 (12), p.2861-2864 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.